Marketers are anticipating strong demand this festive season, propelled by the Union government’s GST rate cut and buoyant consumer sentiment. Discretionary spending is expected to rise, particularly ...

Across several clinical outcomes, including 28-day mortality, beta-blocker esmolol was more effective than standard care and ...

Clevetura might have just changed the game. The CLVX S is a compact touch sensitive keyboard where the keys themselves become ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer after ...